Key words: IgE, IgG, allergen components, respiratory allergens, food allergens, EGEA, cohort, epidemiology, MeDALL, microarray Allergic patients are characterized by the production of specific IgE antibodies against allergens, 1 whereas allergen-specific IgG antibodies occur in both allergic and nonallergic individuals. 2 Allergen-specific IgG antibodies play a role in allergen-specific clinical tolerance, either occurring naturally or induced by allergen-specific immunotherapy. [3] [4] [5] [6] [7] For certain allergens, IgE and IgG responses differ. 8 Allergen-specific IgG antibodies may be associated with exposure to the respective allergen. 9, 10 However, population data regarding the role of the production of IgG antibodies to a broad panel of common food and inhalant allergens are not available.
The route and dose of exposure to allergens are highly relevant for IgE and IgG sensitization. The oral route may favor an IgG response, whereas inhaled exposure may favor an IgE response. 8, 11 Investigating the IgG response to several molecule groups such as profilins (eg, Bet v 2 and Phl p 12), including both inhalant and food allergens, or polcalcins, that is, calciumbinding allergens (eg, Bet v 4 and Phl p 7), including only inhalant allergens, could provide additional insight into the role of the route of exposure for allergic sensitization.
The microarray technology allows measurement of allergenspecific IgE and IgG antibody responses to many allergen components. In European Union-funded project Mechanisms of the Development of Allergy (MeDALL), the ImmunoCAP ISAC chip technology was improved to increase its sensitivity and to incorporate new allergens. [12] [13] [14] [15] [16] The resulting MeDALL chip has been validated 15, 16 and more than 6000 sera from 7 European birth cohorts (eg, Barn, Allergi, Milj€ o, Stockholm, Epidemiologi [BAMSE] and Environment and Childhood Asthma [ECA]) 17, 18 have been tested so far.
The Epidemiological study of the Genetics and Environment of Asthma, bronchial hyperresponsivness and atopy (EGEA) [19] [20] [21] is a cohort of adults and children with and without asthma recruited in 5 French cities (Paris, Lyon, Grenoble, Montpellier, and Marseille). Pollen exposure varies widely among these different places. Grass pollen exposure is similar across France, whereas exposure to pollens of birch, cypress, and ragweed exhibits strong geographical variability.
As part of the MeDALL project, 15 the present study investigates the geographical variability of allergen-specific IgE and IgG antibodies toward a large variety of different respiratory and food allergens using the MeDALL microarray technology in sera from the EGEA cohort obtained from subjects recruited in different places in France. We addressed whether there are differences among the types of allergens, routes of allergen exposure, and levels of respiratory allergen exposure on the production of allergen-specific IgE and IgG antibodies.
METHODS

Population and study setting
The EGEA cohort is composed of patients with asthma enrolled in chest clinics and their first-degree relatives, and a group of control subjects, all recruited in the early 1990s in 5 French cities. Protocol and characteristics have been previously published. 22, 23 Briefly, 2047 participants were enrolled at baseline (EGEA1) including 388 children (<16 years) and adult patients with asthma from chest clinics, their 1244 first-degree relatives, and 415 population-based control subjects. Subjects were recruited through self-completed questionnaires and an overall matching by months at examination, age (decade), sex, and center. About 11 years later, this population was invited for a follow-up (EGEA2) and 1601 participants (77.1% of the original cohort 1 58 new family members) were subjected to a complete examination, which included serum samples. 21 EGEA collection is certified ISO 9001 and referenced in the Biobank network by the number BB-0033-00043.
The present analysis was conducted in 340 adult participants obtained at the follow-up (ie, EGEA2) (170 with and 170 without asthma). Participants were randomly selected among all followed-up subjects with available serum and data on genetic polymorphisms (to facilitate further analyses), skin prick tests (SPTs), and total IgE at baseline (EGEA1) and follow-up (EGEA2) visits and nonmissing data for asthma status.
Written consent was obtained from all individuals. Ethical approval was obtained for both surveys (Cochin Royal Hospital, Paris, for EGEA1 and Necker-Enfants Malades Hospital, Paris, for EGEA2).
Asthma, allergic rhinitis phenotypes, and SPTs
The definition of ever asthma was based on a positive answer to either ''Have you ever had attacks of breathlessness at rest with wheezing?'' or ''Have you ever had asthma attacks?'' or being recruited as an asthma case. 23 Allergic rhinitis ever was defined by a positive answer to ''Have you ever had allergic rhinitis?'' or ''Have you ever had hay fever?'' Subjects with a positive answer to ''Have you had a problem with sneezing or runny or blocked nose when you did not have a cold or flu in the last 12 months'' have been defined as active allergic rhinitis.
SPT was performed for 11 allergens (cat, Dermatophagoides pteronyssinus, Blattela germanica, olive, birch, Parieteria judaica, timothy grass, ragweed pollen, Aspergillus, Cladosporium herbarum, Alternaria tenuis). Positive SPT result was defined by a mean wheal diameter of 3 mm or more.
Measurement of allergen-specific IgE and IgG levels with the MeDALL allergen-chip
IgE and IgG levels were determined in anonymized samples with the MeDALL allergen-chip as described. 15, 16 It comprises 176 allergen components including aero-and food allergen components. The measurement of allergen-specific IgE and IgG reactivities was performed as described. 16, 18, 24 The present study was focused on outdoor allergen sources whose distribution varied in the different geographical areas (birch pollen, cypress pollen, ragweed pollen, olive/ash pollen, timothy grass pollen) and on allergens from indoor allergen sources (house dust mites). We studied IgG to the pathogenesis-related protein family PR-10 (PR-10) group of allergens with cross-reactive food allergens. 18 To further address the hypothesis that allergen contact mainly by the oral route induces IgG response, 3 common food allergens were also studied (milk, egg, fish), allowing us to compare the frequency of IgE and IgG recognition across respiratory and food allergens. Overall, 47 representative allergen components were analyzed in detail.
Geographical exposure to allergens
The geographical distribution of the studied pollens across France in 2006 was obtained from the R eseau National de Surveillance A erobiologique, the 
Biases
The random selection of the EGEA2 participants to the present analysis was a priori unrelated to allergen exposure and allergic status, minimizing the risk for selection bias. In both subjects with and without asthma, subjects included in the analysis did not differ regarding allergic sensitization as defined by 1 or more positive reaction in SPT using 12 different extracts, level of total IgE, and allergic rhinitis phenotype as compared with exluded participants (see Table E1 in this article's Online Repository at www.jacionline.org). Regarding exposure we did not observe marked differences between included and excluded subjects, although included subjects with asthma were more often recruited in Lyon and Grenoble (Table E1) .
Statistical methods
According to previous studies, IgE and IgG positivity to allergen was defined by a threshold of 0.3 ISU and 0.5 ISU, respectively. [16] [17] [18] Ordinal categorical variables were also studied both for IgE (<0.3 <1 <3 <10 <30 and > _30 ISU) and for IgG (<0.5 <1.5 <5 <15 <50 and > _50 ISU) because of the non-Gaussian distribution. Chi-square test was used when applicable. Nonparametric Kruskal-Wallis tests were also applied to address whether the IgE and IgG levels (considered as continuous outcomes) differed among centers. Odds ratios were estimated to assess the magnitude of the association between centers and allergen-specific IgE (or IgG) sensitization using multinomial logistic regression adjusted on age, sex, asthma, and rhinitis status.
RESULTS
Characteristics of study subjects
In this study, 340 sera from different centers (Paris: n 5 96; Lyon: n 5 75; Marseille: n 5 41; Montpellier: n 5 22; Grenoble: n 5 106) were available. The demographic characteristics of participants are presented in Table I . The population included 47% men, and the mean age was 43 years. Fifty-two percent of participants had allergic rhinitis ever and 37.6% had atopic dermatitis ever. Eighty-two participants reported having received some form of allergen immunotherapy (AIT).
Allergens most frequently recognized by IgE
Overall, 48.8% of the population had allergen-specific IgE level of 0.3 ISU or more to at least 1 of the allergen components selected, which is in strong agreement with the prevalence of atopy (defined by positive SPT result to at least 1 of 11 aeroallergen extracts) in this population (Cohen k coefficient 5 0.68). The agreement between SPT and allergenspecific IgE was strong for each allergen (see Table E2 (Table II) . Regarding food allergens, the family of PR-10 proteins (ie, Mal d 1: apple; Cor a 1.0401: hazelnut; Ara h 8: peanut; Pru p 1: cherry; Gly m 4: soy) that cross-react with the major birch pollen allergen Bet v 1 were most frequently recognized by IgE (from 2.4% to 7.6% of patients), followed by Gal d 1 (ovomucoid, egg) and Bos d 4 (lactalbumin, milk), with 0.6% and 0.3%. These patterns were consistent in the population that did not receive AIT, although the prevalence of IgE recognition was lower as compared with the whole study population (Table II) .
Similarities and discrepancies between IgE and IgG recognition
Distinct patterns of IgE and IgG recognition frequencies were found (Table II) . In general, respiratory allergens (Ole e 1, Phl p 1, Phl p 4, Der p 1, Der p 2, Der p 23, Fel d 1) frequently recognized by IgE antibodies (> _20% subjects) were frequently recognized by IgG as well (> _60% subjects). Likewise, some respiratory allergens less frequently recognized by IgE antibodies (< _6% subjects) were also recognized at low frequency (ie, <40%) by IgG (Phl p 7, Phl p 11, Bet v 4, Ole e 7, Amb a 1). However, other respiratory allergens also less frequently recognized by IgE antibodies were recognized in more than 80% by IgG (Phl p 12, Bet v 2, Ole e 9). Similar patterns were observed in the population without AIT.
Geographical variation of IgE and IgG recognition
Although the IgE sensitization to at least 1 of the analyzed allergens (Table II) did not vary significantly across the geographical areas (from 39.0% to 54.7%; P 5 .46), we observed considerable geographical differences for some specific allergens (Fig 1 and Table III) .
For several major respiratory allergens, the IgE and IgG frequencies in the different regions followed to a large extent the exposure levels with the corresponding allergen sources (eg, Similar patterns were observed in subjects with and in subjects without asthma (see Table E3 in this article's Online Repository at www.jacionline.org), as well as in subjects without AIT (see Table E4 in this article's Online Repository at www.jacionline.org), although results should be interpreted cautiously because of the sample size. However, for Bet v 1 the geographic pattern of IgE and IgG recognition differed. IgE recognition frequencies to Bet v 1 followed the exposure levels of birch pollen in the different regions, whereas IgG recognition was high (>60%) in all regions. This was also observed for food allergens that showed immunological cross-reactivity with Bet v 1 (PR-10 proteins, eg, Mal d 1 from apple, Cor a 1.0401 from hazelnut, Ara h 8 from peanut, Pru p 1 from cherry, and Gly m 4 from soy) (Fig 1) .
Regarding ubiquitously occurring allergens such as highly cross-reactive plant allergens (calcium-binding allergens: Phl p 7 and Bet v 4; profilins: Phl p 12 and Bet v 2), house dust mite allergens (eg, Der p 1, Der p 2, Der p 23, Der p 10, Der p 11, and Der p 14), and food allergens whose sensitization occurs primarily by the oral route (eg, Bos d 4, Gal d 1, and Gad c 1), we found little geographic variation for IgE and IgG recognition frequencies (Figs 1 and 2) . Nevertheless, for some of these allergen components, IgG concentrations varied across the regions (as indicated by the nonparametric Kruskal-Wallis test estimated on the continuous variables) and IgE reactivity against major indoor allergens from house dust mite (ie, Der p 2, Der p 23, Der p 1) tended to be lower in Lyon and Marseille (Fig 2) . In each region, Der p 10, Der p 11, and Der p 14, for which exposure also occurs via the gut (Der p 10 cross-reacts with tropomyosin from shrimp) or the skin, were rarely recognized by IgE but frequently by IgG (Table II and Fig 2) .
Very few subjects showed IgE reactivity to allergens of milk (Bos d 4) and egg (Gal d 1), and these allergens were recognized by IgG in about 90% of the subjects with no differences across the geographical areas (Fig 3) . , and timothy grass (Phl p 1) (E) and for cross-reactive pollen allergens timothy grass polcalcin (Phl p 7) (F), birch polcalcin (Bet v 4) (G), timothy grass profilin (Phl p 12) (H), and birch profilin (Bet v 2) (I), and for the Bet v 1-related food allergen from apple (Malus domestica 1) (J) in different regions of France. Shown are the percentages of subjects (y-axes) with IgE (upper panels) and IgG reactivity (middle panels) to the allergens in the different cities of France (x-axes) and the pollen counts in the different areas of France (lower panels). Antibody levels are color-coded and shown in ISU. P values assessing the differences across centers were estimated from the nonparametric Kruskal-Wallis test.
DISCUSSION
Microarrayed allergens are increasingly used to determine the molecular profile of IgE sensitization in populations. 27, 28 However, to our knowledge, the present study is the first systematic study comparing IgE and IgG responses to a large panel of respiratory and food allergens in a geographically defined population. It shows a large geographical variability in the distribution of IgE and IgG antibodies in France, which could be summarized as follows: (1) for ubiquitous allergens such as pollens of grass, olive/ash, and to a lesser extent allergens from house dust mites, IgE antibodies were scattered around the different French regions (up to 34% of participants) and IgG antibodies were present in most subjects without any geographical difference (>85%). (2) However, for regional pollen (ragweed, birch, cypress), IgE responses mirrored regional pollen exposure, but the IgG responses varied depending on allergen sources: high for pollen allergens cross-reacting with food allergens (Bet v 1 and other PR-10 allergen components) and glycosylated components (eg, Cup a 1 and Phl p 4), 29 low for the other pollen allergens with only respiratory exposure, and no cross-reactivity with food allergens (eg, ragweed). (3) For food allergens, IgG responses were frequent whereas IgE responses were rare. These results indicate that contact with allergen by the oral route may preferentially induce IgG responses whereas allergen contact by the respiratory route appears important for IgE sensitization.
Strengths and weaknesses
One strength lies in the solid phenotypic characterization of a large population, with a fair distribution of asymptomatic subjects and subjects with asthma and/or rhinitis. As in most epidemiological settings, the definitions of asthma and rhinitis were based on a standardized questionnaire, which might have led to misclassification bias on the disease status, but should not have biased our results on the effects of the geographical area and routes of exposure in IgE and IgG recognition. As compared with the general population, our study population is enriched with subjects with asthma and consequently has higher percentages of IgE sensitizations, leading to an increased statistical power to address allergen-specific IgE responses. Indeed, because the main aim of the present study was the parallel analysis of allergen-specific IgE and IgG responses toward a comprehensive set of allergen molecules to dissect variations in geographic sensitization profiles and possible routes of sensitization, a normal population would not have been appropriate because the percentage of allergic subjects would have been too low and it would have required a much larger sample size. This population selection should not have affected our results on the geographical variability of IgE and IgG sensitization, but does not allow assessing the community-based prevalence of IgE and IgG responses. The study is specific to France, but can help to understand and assess the differences between ubiquitous and regional allergens in other countries as well as IgE and IgG responses to allergens in general.
The effect of immunotherapy on specific IgE or specific IgG levels could not be tested because only allergic patients had received this form of treatment and there will necessarily be higher frequencies of IgE recognition in individuals who received AIT than in those who did not. However, the frequency of subjects who had received AIT was similar across centers and even though AIT induces IgG it does not completely eliminate IgE reactivity to the microarrayed allergens and therefore does not affect the geographic IgE results. Although we do not have detailed information on AIT (regarding the targeted allergens), we do not think that AIT might differentially influence the IgE/IgG profile according to the allergen. For instance, it is unlikely that subjects in areas without birch pollen developed IgG against this allergen (ie, Bet v 1 and Bet v 1-related food allergens) due to AIT because birch pollen-specific AIT was probably not prescribed in this area. Also, naturally occurring IgG does not affect IgE recognition in the chip analysis because naturally occurring IgG seems to react with epitopes different from those recognized by IgE. 8 Finally, the sensitivity analysis conducted among subjects not having received AIT showed strong robustness of the observed associations.
The exposure to allergens was not addressed at the individual level, but by study center locations. This ecological approach for exposure assessment might be a source of exposure misclassification, characterized here by the Berkson error type, which has been shown to weaken the precision of the estimates, but as compared with the classical error does not induce major bias on risk estimates. 30 Also, we considered the center of recruitment and did not take into account the residential history of the participants. This may have led to exposure misclassification because some individuals might have lived in different areas with potentially different exposures.
A major strength relates to the use of the improved microarray technology, which contains a larger number of important allergens than do the commercial ISAC chips. 15, 16 The MeDALL chip used in this study is as sensitive for IgE detection as the quantitative ImmunoCAP assay and can be used also for the detection of allergen-specific IgG responses with high specificity and sensitivity. 15, 16 Furthermore, the allergen repertoire on the MeDALL chip covers most of the relevant allergen sources. 17 Although IgG can interfere with IgE binding on allergen microarrays, we have proven that it does not affect the sensitivity to pick up sensitizations. 17 Moreover, we found that IgE results were in good agreement with results obtained by skin prick testing.
Interpretation of the results
In accordance with a recent cross-sectional analysis in the United States, IgE sensitization to at least 1 of the studied allergens did not vary across the French regions but allergenspecific sensitization against some allergen components exhibited geographical variations. 31 This may indicate that genetic susceptibility for sensitization, probably similar across the country, favors an IgE immune response in the same percentage of the population overall, but specificities of IgE reactions are linked to exposure. Indeed, chip testing reveals that the molecular IgE sensitization profile for respiratory allergens in France correlates very well with exposure data: some plants being prevalent in defined areas (birch, ragweed, and cypress) and some allergen sources being found across France (grass, olive/ ash pollen). [32] [33] [34] Patients with a subclinical sensitization to birch pollen exist in an area without atmospheric birch pollen exposure. 35 For cypress pollen, IgE patterns also reflect pollen dispersion but IgG is found in most participants because of the carbohydrate nature of the allergen, which makes it a panallergen. 29 The lower IgE recognition frequency of Der p 1 and Der p 2 in Lyon was a priori not expected but might be related to factors such as living habits.
Some respiratory allergens induce IgG only in few patients because they are poorly immunogenic (eg, Phl p 2) but nevertheless they often lead to IgE sensitization. 36, 37 This follows properties of the antigens themselves. We found that IgG reactivity to the highly cross-reactive pollen allergens Phl p 12 and Bet v 2 (ie, profilins) 38 and PR-10 proteins 39 was very
common in each region, whereas IgE and IgG reactivity to another class of cross-reactive pollen allergens, the calciumbinding allergens from birch (Bet v 4) and timothy grass (Phl p 7), was low in all regions. PR-10 and profilins are present in pollen and plant-derived foods, whereas the polcalcins, that is, calcium-binding allergen components, are present only in pollen. This probably explains the differences in IgG reactivity between PR-10 and profilins (high) in comparison to calcium-binding components (low). This is supported by a recent study suggesting that foodborne PR-10 allergens initiate an early IgG response to PR-10 molecules but no IgE response. 11 Certain house dust mite allergens that are rare targets for IgE (Der p 10, Der p 11, and Der p 14, <10% in our population) are frequently recognized by IgG antibodies (>60% in our population). Interestingly, these allergens are mainly present in mite bodies and therefore allergen contact occurs mainly via the skin 40 or via cross-reactive food allergens (eg, Der p 10 is cross-reactive with tropomyosin from shrimp).
In conclusion, the results from the analysis of IgE and IgG responses against a comprehensive set of respiratory and food allergens in the present study suggest that IgG response is related to exposure via the respiratory tract, the gastrointestinal tract, and possibly via the skin whereas IgE sensitization occurs mainly when the subject is exposed via the respiratory tract. However, only a fraction of these subjects develops IgE antibodies. 18 The results of the present study will be valuable for better understanding when allergen-specific interventions such as avoidance or immunotherapy should be undertaken or not. We thank Rob Aalberse, Amsterdam, The Netherlands, for thoughtful discussions.
Key messages
d IgE and IgG antibodies toward respiratory allergens are usually associated with inhalant allergen exposures, but IgG is frequent in subjects exposed to cross-reacting food allergens. 
